126 related articles for article (PubMed ID: 38536023)
1. TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia.
Alqahtani M; Aljuaimlani A; Al-Tamimi J; Alomar S; Mansour L
Hematology; 2024 Dec; 29(1):2329024. PubMed ID: 38536023
[TBL] [Abstract][Full Text] [Related]
2. Association of Polymorphisms in PD-1 and LAG-3 Genes with Acute Myeloid Leukemia.
Mansour L; Alqahtani M; Aljuaimlani A; Al-Tamimi J; Al-Harbi N; Alomar S
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792904
[No Abstract] [Full Text] [Related]
3. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
[TBL] [Abstract][Full Text] [Related]
4. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
Wu Z; Ou J; Liu N; Wang Z; Chen J; Cai Z; Liu X; Yu X; Dai M; Zhou H
Cancer Med; 2023 Apr; 12(7):8956-8969. PubMed ID: 36545697
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint-related gene polymorphisms are associated with acute myeloid leukemia.
Wu Y; Li M; Meng G; Ma Y; Ye J; Sun T; Ji C
Cancer Med; 2023 Sep; 12(18):18588-18596. PubMed ID: 37602517
[TBL] [Abstract][Full Text] [Related]
8. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
9. Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
Dama P; Tang M; Fulton N; Kline J; Liu H
J Immunother Cancer; 2019 Jul; 7(1):175. PubMed ID: 31291985
[TBL] [Abstract][Full Text] [Related]
10. One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia.
Wang Z; Chen J; Wang M; Zhang L; Yu L
Front Immunol; 2021; 12():618710. PubMed ID: 33868234
[TBL] [Abstract][Full Text] [Related]
11. Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3.
Liu CW; Wu LS; Lin CJ; Wu HC; Liu KC; Lee SW
PLoS One; 2024; 19(5):e0303431. PubMed ID: 38723011
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia.
Wang J; Yang L; Dao FT; Wang YZ; Chang Y; Xu N; Chen WM; Jiang Q; Jiang H; Liu YR; Qin YZ
Leuk Lymphoma; 2022 Jan; 63(1):152-161. PubMed ID: 34405769
[TBL] [Abstract][Full Text] [Related]
13. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S
Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
Hammrich J; Wittig S; Ernst T; Gruhn B
Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
[TBL] [Abstract][Full Text] [Related]
15. C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation.
Al Shahrani M; Gahtani RM; Makkawi M
Med Oncol; 2024 Jan; 41(3):63. PubMed ID: 38265498
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
Front Immunol; 2021; 12():607966. PubMed ID: 33717091
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
[TBL] [Abstract][Full Text] [Related]
18. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
Jajosky AN; Coad JE; Vos JA; Martin KH; Senft JR; Wenger SL; Gibson LF
Stem Cells Transl Med; 2014 Jul; 3(7):836-48. PubMed ID: 24855276
[TBL] [Abstract][Full Text] [Related]
19. Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Lamble AJ; Kosaka Y; Laderas T; Maffit A; Kaempf A; Brady LK; Wang W; Long N; Saultz JN; Mori M; Soong D; LeFave CV; Huang F; Adams H; Loriaux MM; Tognon CE; Lo P; Tyner JW; Fan G; McWeeney SK; Druker BJ; Lind EF
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14331-14341. PubMed ID: 32513686
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.
Gonçalves Silva I; Gibbs BF; Bardelli M; Varani L; Sumbayev VV
Oncotarget; 2015 Oct; 6(32):33823-33. PubMed ID: 26413815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
